• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乌干达新抵达难民不同人群中抗疟药物耐药标志物的流行率各不相同。

Varied Prevalence of Antimalarial Drug Resistance Markers in Different Populations of Newly Arrived Refugees in Uganda.

机构信息

Makerere University, Kampala, Uganda.

Infectious Diseases Research Collaboration, Kampala, Uganda.

出版信息

J Infect Dis. 2024 Aug 16;230(2):497-504. doi: 10.1093/infdis/jiae288.

DOI:10.1093/infdis/jiae288
PMID:38874098
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11326807/
Abstract

Newly arrived refugees offer insights into malaria epidemiology in their countries of origin. We evaluated asymptomatic refugee children within 7 days of arrival in Uganda from South Sudan and the Democratic Republic of Congo (DRC) in 2022 for parasitemia, parasite species, and Plasmodium falciparum drug resistance markers. Asymptomatic P. falciparum infections were common in both populations. Coinfection with P. malariae was more common in DRC refugees. Prevalences of markers of aminoquinoline resistance (PfCRT K76T, PfMDR1 N86Y) were much higher in South Sudan refugees, of antifolate resistance (PfDHFR C59R and I164L, PfDHPS A437G, K540E, and A581G) much higher in DRC refugees, and of artemisinin partial resistance (ART-R; PfK13 C469Y and A675V) moderate in both populations. Prevalences of most mutations differed from those seen in Ugandans attending health centers near the refugee centers. Refugee evaluations yielded insights into varied malaria epidemiology and identified markers of ART-R in 2 previously little-studied countries.

摘要

新到达的难民提供了有关其原籍国疟疾流行病学的见解。我们评估了 2022 年在乌干达从南苏丹和刚果民主共和国(DRC)新抵达的无症状难民儿童的寄生虫血症、寄生虫种类和恶性疟原虫抗药性标志物。在这两个群体中,无症状恶性疟原虫感染都很常见。在 DRC 难民中,疟原虫疟原虫与疟原虫疟原虫的合并感染更为常见。在南苏丹难民中,抗疟喹啉耐药性标志物(PfCRT K76T、PfMDR1 N86Y)的流行率要高得多,在 DRC 难民中,抗叶酸耐药性标志物(PfDHFR C59R 和 I164L、PfDHPS A437G、K540E 和 A581G)的流行率要高得多,而青蒿素部分耐药性(ART-R;PfK13 C469Y 和 A675V)在两个群体中均为中度。大多数突变的流行率与在难民中心附近的卫生中心就诊的乌干达人不同。难民评估提供了对不同疟疾流行病学的见解,并在两个以前研究较少的国家发现了抗青蒿素药物耐药性的标志物。

相似文献

1
Varied Prevalence of Antimalarial Drug Resistance Markers in Different Populations of Newly Arrived Refugees in Uganda.乌干达新抵达难民不同人群中抗疟药物耐药标志物的流行率各不相同。
J Infect Dis. 2024 Aug 16;230(2):497-504. doi: 10.1093/infdis/jiae288.
2
Comprehensive analysis of molecular markers linked to antimalarial drug resistance in Plasmodium falciparum in Northern, Northeastern and Eastern Uganda.乌干达北部、东北部和东部恶性疟原虫抗疟药物耐药性相关分子标记的综合分析。
Malar J. 2025 Jun 13;24(1):190. doi: 10.1186/s12936-025-05439-x.
3
Resistance-mediating polymorphisms in Plasmodium falciparum infections in Kinshasa, Democratic Republic of the Congo.刚果民主共和国金沙萨恶性疟原虫感染中与耐药性相关的多态性
Am J Trop Med Hyg. 2009 Apr;80(4):555-8.
4
A comprehensive survey of polymorphisms conferring anti-malarial resistance in Plasmodium falciparum across Pakistan.巴基斯坦恶性疟原虫抗疟耐药性相关多态性的全面调查。
Malar J. 2013 Aug 29;12:300. doi: 10.1186/1475-2875-12-300.
5
A retrospective analysis of drug resistance markers detects an early (2016/17) high prevalence of the k13 C469Y mutation in asymptomatic infections in Northern Uganda.对耐药标志物的回顾性分析发现,在乌干达北部无症状感染中,早期(2016/17 年)就出现了 k13 C469Y 突变的高流行率。
Antimicrob Agents Chemother. 2024 Sep 4;68(9):e0157623. doi: 10.1128/aac.01576-23. Epub 2024 Aug 13.
6
Prevalence of Plasmodium falciparum parasites resistant to sulfadoxine/pyrimethamine in the Democratic Republic of the Congo: emergence of highly resistant pfdhfr/pfdhps alleles.在刚果民主共和国流行对磺胺多辛/乙胺嘧啶具有抗药性的恶性疟原虫寄生虫:出现高度抗药性的 pfdhfr/pfdhps 等位基因。
J Antimicrob Chemother. 2018 Oct 1;73(10):2704-2715. doi: 10.1093/jac/dky258.
7
Molecular epidemiology of drug resistance markers of Plasmodium falciparum in Yunnan Province, China.中国云南省疟原虫耐药标志物的分子流行病学研究。
Malar J. 2012 Jul 28;11:243. doi: 10.1186/1475-2875-11-243.
8
Identification of the PfK13 mutations R561H and P441L in the Democratic Republic of Congo.鉴定刚果民主共和国 PfK13 突变株 R561H 和 P441L。
Int J Infect Dis. 2024 Feb;139:41-49. doi: 10.1016/j.ijid.2023.11.026. Epub 2023 Nov 26.
9
Prevalence of Plasmodium falciparum Molecular Markers of Antimalarial Drug Resistance in a Residual Malaria Focus Area in Sabah, Malaysia.马来西亚沙巴州一个残留疟疾流行重点地区恶性疟原虫抗疟药物耐药性分子标志物的流行情况
PLoS One. 2016 Oct 27;11(10):e0165515. doi: 10.1371/journal.pone.0165515. eCollection 2016.
10
Identification of polymorphisms in genes associated with drug resistance in Plasmodium falciparum isolates from school-age children in Kinshasa, Democratic Republic of Congo.刚果民主共和国金沙萨学龄儿童恶性疟原虫分离株中与耐药性相关基因多态性的鉴定。
Parasitol Int. 2022 Jun;88:102541. doi: 10.1016/j.parint.2022.102541. Epub 2022 Jan 17.

引用本文的文献

1
Rising prevalence of Plasmodium falciparum Artemisinin partial resistance mutations in Ethiopia.埃塞俄比亚恶性疟原虫青蒿素部分耐药性突变的流行率上升。
Commun Med (Lond). 2025 Jul 18;5(1):297. doi: 10.1038/s43856-025-01008-0.
2
Comprehensive analysis of molecular markers linked to antimalarial drug resistance in Plasmodium falciparum in Northern, Northeastern and Eastern Uganda.乌干达北部、东北部和东部恶性疟原虫抗疟药物耐药性相关分子标记的综合分析。
Malar J. 2025 Jun 13;24(1):190. doi: 10.1186/s12936-025-05439-x.
3
Slowing the spread of treatment failure to artemisinin-based combination therapies in Uganda.减缓乌干达基于青蒿素的联合疗法治疗失败的传播速度。
medRxiv. 2025 May 18:2025.05.15.25327701. doi: 10.1101/2025.05.15.25327701.

本文引用的文献

1
Emergence, transmission dynamics and mechanisms of artemisinin partial resistance in malaria parasites in Africa.非洲青蒿素部分耐药疟原虫的出现、传播动态和机制。
Nat Rev Microbiol. 2024 Jun;22(6):373-384. doi: 10.1038/s41579-024-01008-2. Epub 2024 Feb 6.
2
Identification of the PfK13 mutations R561H and P441L in the Democratic Republic of Congo.鉴定刚果民主共和国 PfK13 突变株 R561H 和 P441L。
Int J Infect Dis. 2024 Feb;139:41-49. doi: 10.1016/j.ijid.2023.11.026. Epub 2023 Nov 26.
3
Evolution of Partial Resistance to Artemisinins in Malaria Parasites in Uganda.乌干达疟原虫对青蒿素类药物部分耐药性的演变。
N Engl J Med. 2023 Aug 24;389(8):722-732. doi: 10.1056/NEJMoa2211803.
4
Determinants of malaria infections among children in refugee settlements in Uganda during 2018-2019.2018-2019 年乌干达难民营中儿童疟疾感染的决定因素。
Infect Dis Poverty. 2023 Apr 10;12(1):31. doi: 10.1186/s40249-023-01090-3.
5
Plasmodium falciparum resistance to artemisinin-based combination therapies.恶性疟原虫对青蒿素类复方疗法的抗药性。
Curr Opin Microbiol. 2022 Oct;69:102193. doi: 10.1016/j.mib.2022.102193. Epub 2022 Aug 22.
6
Artemisinin and multidrug-resistant Plasmodium falciparum - a threat for malaria control and elimination.青蒿素和耐多药恶性疟原虫——对疟疾控制和消除的威胁。
Curr Opin Infect Dis. 2021 Oct 1;34(5):432-439. doi: 10.1097/QCO.0000000000000766.
7
Health of African Refugee Children Outside Africa: A Scoping Review.非洲境外非洲难民儿童的健康:范围综述。
J Pediatr Nurs. 2021 Nov-Dec;61:199-206. doi: 10.1016/j.pedn.2021.06.001. Epub 2021 Jun 9.
8
The impact of stopping and starting indoor residual spraying on malaria burden in Uganda.停止和启动室内残留喷洒对乌干达疟疾负担的影响。
Nat Commun. 2021 May 11;12(1):2635. doi: 10.1038/s41467-021-22896-5.
9
Changing Prevalence of Potential Mediators of Aminoquinoline, Antifolate, and Artemisinin Resistance Across Uganda.乌干达各地潜在的氨基喹啉、抗叶酸和青蒿素耐药性中介体的流行率变化。
J Infect Dis. 2021 Mar 29;223(6):985-994. doi: 10.1093/infdis/jiaa687.
10
Antimalarial drug resistance in Africa: the calm before the storm?非洲的抗疟药物耐药性:暴风雨前的平静?
Lancet Infect Dis. 2019 Oct;19(10):e338-e351. doi: 10.1016/S1473-3099(19)30261-0. Epub 2019 Jul 30.